Published 19 September 2005. doi:10.1084/jem.20050665
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 202, Number 6, 841-851
Cytosolic phospholipase A2
deficient mice are resistant to experimental autoimmune encephalomyelitis
Suzana Marusic1,
Michael W. Leach2,
Jeffrey W. Pelker1,
Mihai L. Azoitei1,
Naonori Uozumi3,
Junqing Cui1,
Marina W.H. Shen1,
Charlene M. DeClercq1,
Joy S. Miyashiro1,
Brenda A. Carito2,
Paresh Thakker1,
David L. Simmons1,
John P. Leonard1,
Takao Shimizu3, and
James D. Clark1
1 Department of Inflammation, Wyeth Research, Cambridge, MA 02140
2 Exploratory Drug Safety, Wyeth Research, Andover, MA 01810
3 Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Tokyo, Tokyo 113-0033, Japan
CORRESPONDENCE Suzana Marusic: smarusic{at}wyeth.com
Experimental autoimmune encephalomyelitis (EAE), a Th1-mediated inflammatory disease of the central nervous system (CNS), is a model of human multiple sclerosis. Cytosolic phospholipase A2
(cPLA2
), which initiates production of prostaglandins, leukotrienes, and platelet-activating factor, is present in EAE lesions. Using myelin oligodendrocyte glycoprotein (MOG) immunization, as well as an adoptive transfer model, we showed that cPLA2
/ mice are resistant to EAE. Histologic examination of the CNS from MOG-immunized mice revealed extensive inflammatory lesions in the cPLA2
+/ mice, whereas the lesions in cPLA2
/ mice were reduced greatly or completely absent. MOG-specific T cells generated from WT mice induced less severe EAE in cPLA2
/ mice compared with cPLA2
+/ mice, which indicates that cPLA2
plays a role in the effector phase of EAE. Additionally, MOG-specific T cells from cPLA2
/ mice, transferred into WT mice, induced EAE with delayed onset and lower severity compared with EAE that was induced by control cells; this indicates that cPLA2
also plays a role in the induction phase of EAE. MOG-specific T cells from cPLA2
/ mice were deficient in production of Th1-type cytokines. Consistent with this deficiency, in vivo administration of IL-12 rendered cPLA2
/ mice susceptible to EAE. Our data indicate that cPLA2
plays an important role in EAE development and facilitates differentiation of T cells toward the Th1 phenotype.
Abbreviations used: 5-LO, 5-lipoxygenase; AA, arachidonic acid; AACOCF3, arachidonyl trifluoromethylketone; CNS, central nervous system; cPLA2
, cytosolic phospholipase A2
; CSF, cerebrospinal fluid; EAE, experimental autoimmune encephalomyelitis; LT, leukotriene; MCP, monocyte chemoattractant protein; MOG, myelin oligodendrocyte glycoprotein; MS, multiple sclerosis; PAF, platelet-activating factor; PG, prostaglandin.
J.P. Leonard's present address is Genzyme Drug Discovery & Development, Waltham, MA 02451.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Kihara, Y., Yanagida, K., Masago, K., Kita, Y., Hishikawa, D., Shindou, H., Ishii, S., Shimizu, T.
(2008). Platelet-Activating Factor Production in the Spinal Cord of Experimental Allergic Encephalomyelitis Mice via the Group IVA Cytosolic Phospholipase A2-Lyso-PAFAT Axis. J. Immunol.
181: 5008-5014
[Abstract]
[Full Text]
-
Uozumi, N., Kita, Y., Shimizu, T.
(2008). Modulation of Lipid and Protein Mediators of Inflammation by Cytosolic Phospholipase A2{alpha} during Experimental Sepsis. J. Immunol.
181: 3558-3566
[Abstract]
[Full Text]
-
Mizui, M., Shikina, T., Arase, H., Suzuki, K., Yasui, T., Rennert, P. D., Kumanogoh, A., Kikutani, H.
(2008). Bimodal regulation of T cell-mediated immune responses by TIM-4. Int Immunol
20: 695-708
[Abstract]
[Full Text]
-
Xu, L., Han, C., Lim, K., Wu, T.
(2008). Activation of Cytosolic Phospholipase A2{alpha} through Nitric Oxide-induced S-Nitrosylation: INVOLVEMENT OF INDUCIBLE NITRIC-OXIDE SYNTHASE AND CYCLOOXYGENASE-2. J. Biol. Chem.
283: 3077-3087
[Abstract]
[Full Text]
-
Thakker, P., Leach, M. W., Kuang, W., Benoit, S. E., Leonard, J. P., Marusic, S.
(2007). IL-23 Is Critical in the Induction but Not in the Effector Phase of Experimental Autoimmune Encephalomyelitis. J. Immunol.
178: 2589-2598
[Abstract]
[Full Text]
-
Payne, S. G., Oskeritzian, C. A., Griffiths, R., Subramanian, P., Barbour, S. E., Chalfant, C. E., Milstien, S., Spiegel, S.
(2007). The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. Blood
109: 1077-1085
[Abstract]
[Full Text]
-
Liu, L., Graham, G. J., Damodaran, A., Hu, T., Lira, S. A., Sasse, M., Canasto-Chibuque, C., Cook, D. N., Ransohoff, R. M.
(2006). Cutting Edge: The Silent Chemokine Receptor D6 Is Required for Generating T Cell Responses That Mediate Experimental Autoimmune Encephalomyelitis. J. Immunol.
177: 17-21
[Abstract]
[Full Text]